Julius Bock
@jff_bock
PhD Candidate @Cambridge_Uni, @Kings_College 🇬🇧 I President @CUGermanSociety 🇩🇪I Global Shaper @WEF 🗺
ID: 1334434981482016768
03-12-2020 09:51:18
22 Tweet
39 Followers
44 Following
Great interview with Luisa Neubauer. Living in a #sharedworld, I truly believe in the importance of #climatechange as a challenge that concerns all. As #scientists, #managers, #politicians and #futureleaders we should be bold to find creative #solutions that leave no one behind.
We had a very interesting discussion with Professor Claudia Kemfert week about the economic impacts of climate change and energy policies. Thank you for the exciting talk - it was great to have you here Claudia Kemfert! #women in #energy #economics #climatechange #CUGS
** Speaker event with Claudia Roth ** You can register now for our speaker event next week with Claudia Roth! The event is open to all. Grüne im Bundestag 🇪🇺🏳️🌈 Deutscher Bundestag BÜNDNIS 90/DIE GRÜNEN Please sign up here: docs.google.com/forms/d/e/1FAI…
"Erasmus was a strong bridge between Germany and the UK" Great interview last week with Frankfurter Allgemeine about a sad reality. #UK is leaving #ERASMUS in the wake of #Brexit For me, this is a decision that is hard to comprehend. Student exchange is not just about economic benefits. (1/2)
Join us for another great event Cambridge University German Society & Oxford German Society with the Federal Minister of Economics Peter Altmaier. We will discuss the future relationship between #EU & #UK facebook.com/events/4746559… 📅15.03.2021 ⏰17:00 - 18:00 Berlin time ➡️Register lnkd.in/dXHifCf
We are looking forward to welcome Dr. h.c. Thomas Sattelberger, MdB, former board member of #Lufthansa, #Continental and #Telekom tomorrow evening 19:00 MESZ: fb.me/e/2lJOVR7PC He will speak about his leadership and management experience (1/2)
UK Daten zeigen: AstraZeneca und BionTech nach 2. Impfung gleicher Schutz vor Krankheit, 85-90%. AstraZeneca Daten sind zunehmend besser. Abstand 2. Dosis war hier aber ca 12 Wochen. Auch nach 1. Dosis kein Unterschied. AstraZeneca wird stark unterschätzt assets.publishing.service.gov.uk/government/upl…